Soy, Enterolactone, Green Tea May Reduce Adverse Breast Cancer Outcomes

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 23, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 23, 2024 -- Soy, enterolactone, and green tea are associated with reductions in adverse breast cancer outcomes, according to a systematic review and meta-analysis published in the February issue of JNCI Cancer Spectrum.

M. Diana van Die, Ph.D., from Western Sydney University in Penrith, Australia, and colleagues reviewed prospective and retrospective observational studies examining the impact of soybean, lignans, cruciferous vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. Data were included from 32 studies.

The researchers found that the risk for recurrence was reduced in association with soy isoflavones (hazard ratio, 0.74), especially among postmenopausal and estrogen receptor-positive survivors (hazard ratios, 0.72 and 0.82, respectively), with the greatest reduction in risk seen at 60 mg/day. The reduction was mainly at 20 to 40 mg/day for mortality outcomes. An inverse association was seen for soy protein and soy products with cancer-specific mortality for estrogen receptor-positive disease (hazard ratio, 0.75). Serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, was inversely associated with cancer-specific mortality and all-cause mortality (hazard ratios, 0.72 and 0.69, respectively). There were no effects observed for cruciferous vegetables. Prediagnostic green tea intake was associated with a reduced risk for recurrence for stage I and II breast cancer (hazard ratio, 0.56).

"To further inform clinical practice, evidence is required on the impact of dietary and supplemental intakes of phytonutrients introduced or substantially increased following diagnosis and treatment," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-24 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords